IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
Relative valuation derived from Materials sector median benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Multiples adjusted for extreme outliers and non-recurring volatility.
Auditing capital efficiency...
Quality Profile Audit
Score: 50GRADE C+
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation.
Return on Equity
Profit generated per dollar of shareholder equity
-117.0%
Sector: 3.3%
Dividend Analysis audit
INCOME
4.26%
Trailing Yield
$4.26
Per $100 Invested
Solid dividend yield for income-focused strategies.
Est. Payout Ratio
242%HIGH
Analyst Projections
Analyst Consensus
Unlock Valuation Tools
Sign up for free access to institutional-quality research tools.
Based on our 6-factor quantitative model, Chemours Co (CC) receives a "Hold" rating with a composite score of 50.1/100, ranked #697 out of 4446 stocks. Key factor scores: Quality 50/100, Value 74/100, Momentum 62/100. This is quantitative analysis only — not investment advice.
Chemours Co (CC) Stock Analysis — April 2026 Rating, Price, and Forecast
Company Overview — What Does Chemours Co Do?
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure and BaiMax brands for delivering whiteness, brightness, opacity, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical, and others applications. The Chemical Solutions segment comprises a portfolio of industrial chemicals used as raw materials and catalysts for gold production, clean and disinfect, oil and gas, water treatment, electronics, and automotive applications. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware. Chemours Co (CC) is classified as a mid-cap stock in the Materials sector, specifically within the Chemicals industry. The company is led by CEO Mark E. Newman and employs approximately 6,600 people, headquartered in Wilmington, Delaware. With a market capitalization of $3.2B, CC is one of the notable companies in the Materials sector.
Chemours Co (CC) Stock Rating — Hold (April 2026)
As of April 2026, Chemours Co receives a Hold rating with a composite score of 50.1/100 and 3 out of 5 stars from the Blank Capital Research quantitative model.CC ranks #697 out of 4,446 stocks in our coverage universe. Within the Materials sector, Chemours Co ranks #41 of 284 stocks, placing it in the top quartile of its Materials peers. The rating is generated by a multi-factor model that weighs quality (30%), momentum (25%), value (15%), investment (10%), stability (10%), and short interest (10%).
CC Stock Price and 52-Week Range
Chemours Co (CC) currently trades at $22.71. The stock gained $0.87 (4.0%) in the most recent trading session. The 52-week high for CC is $21.85, which means the stock is currently trading 3.9% from its annual peak. The 52-week low is $9.13, putting the stock 148.7% above its annual trough. Recent trading volume was 2.7M shares, reflecting moderate market activity.
Is CC Overvalued or Undervalued? — Valuation Analysis
Chemours Co (CC) carries a value factor score of 74/100 in the Blank Capital model, suggesting the stock trades at a meaningful discount to its fundamental earning power. The trailing price-to-earnings ratio is 56.78x, compared to the Materials sector average of 26.50x — a premium of 114%. The price-to-book ratio stands at 10.72x, versus the sector average of 2.83x. The price-to-sales ratio is 0.54x, compared to 0.74x for the average Materials stock. On an enterprise value basis, CC trades at 0.88x EV/EBITDA, versus 6.01x for the sector.
Based on these multiples, Chemours Co appears attractively valued relative to both its sector peers and the broader market. Value-oriented investors may find the current entry point compelling, particularly if the company's fundamental quality metrics also score well.
Chemours Co Profitability — ROE, Margins, and Quality Score
Chemours Co (CC) earns a quality factor score of 50/100, indicating solid business quality with consistent operational execution. The return on equity (ROE) is -117.0%, compared to the Materials sector average of 3.3%, which is below typical expectations for high-quality companies. Return on assets (ROA) comes in at -4.6% versus the sector average of 0.6%.
On a margin basis, Chemours Co reports gross margins of 17.3%, compared to 29.8% for the sector. The operating margin is 61.4% (sector: 6.0%). Net profit margin stands at -5.4%, versus 3.0% for the average Materials stock. Revenue growth is running at -3.8% on a trailing basis, compared to 1.8% for the sector. The overall profitability profile is adequate, though there may be room for margin expansion.
CC Debt, Balance Sheet, and Financial Health
Chemours Co has a debt-to-equity ratio of 2423.0%, compared to the Materials sector average of 41.0%. This elevated leverage warrants close monitoring, as it increases the company's sensitivity to rising interest rates and economic downturns. The current ratio is 1.71x, suggesting adequate working capital coverage. Total debt on the balance sheet is $4.14B. Cash and equivalents stand at $613M.
CC has a beta of 2.05, meaning it is more volatile than the broader market — a $10,000 investment in CC would be expected to move 105.0% more than the S&P 500 on any given day. The stability factor score for Chemours Co is 31/100, suggesting elevated price swings that may be unsuitable for conservative portfolios.
Chemours Co Revenue and Earnings History — Quarterly Trend
In TTM 2026, Chemours Co reported revenue of $5.99B and earnings per share (EPS) of $0.40. Net income for the quarter was $-351M. Gross margin was 17.3%. Operating income came in at $3.64B.
In Q3 2025, Chemours Co reported revenue of $1.50B and earnings per share (EPS) of $0.40. Net income for the quarter was $60M. Gross margin was 15.6%. Revenue grew -0.9% year-over-year compared to Q3 2024. Operating income came in at $1.36B.
In Q2 2025, Chemours Co reported revenue of $1.61B and earnings per share (EPS) of $-2.54. Net income for the quarter was $-380M. Gross margin was 17.2%. Revenue grew 3.9% year-over-year compared to Q2 2024. Operating income came in at $1.13B.
In Q1 2025, Chemours Co reported revenue of $1.37B and earnings per share (EPS) of $-0.03. Net income for the quarter was $-4M. Gross margin was 17.3%. Revenue grew 0.4% year-over-year compared to Q1 2024. Operating income came in at $1.19B.
Over the past 8 quarters, Chemours Co has demonstrated a growth trajectory, with revenue expanding from $1.36B to $5.99B. Investors analyzing CC stock should weigh these quarterly trends alongside the valuation and quality metrics discussed above.
CC Dividend Yield and Income Analysis
Chemours Co (CC) currently pays a dividend yield of 4.3%. At this yield, a $10,000 investment in CC stock would generate approximately $$426.00 in annual dividend income. This compares to the Materials sector average dividend yield of 0.5%, meaning CC offers above-average income for its sector.
CC Momentum and Technical Analysis Profile
Chemours Co (CC) has a momentum factor score of 62/100, reflecting neutral trend characteristics. The stock is neither significantly outperforming nor underperforming the broader market on a momentum basis. The investment factor score is 35/100, which measures capital allocation efficiency and asset growth patterns. The short interest score of 20/100 signals elevated short interest, which can indicate bearish sentiment among institutional investors.
CC vs Competitors — Materials Sector Ranking and Peer Comparison
Comparing CC against the S&P 500 benchmark is also instructive for understanding relative performance. Investors can view the full CC vs S&P 500 (SPY) comparison to assess how Chemours Co stacks up against the broader market across all factor dimensions.
CC Next Earnings Date
No upcoming earnings date has been announced for Chemours Co (CC) at this time. Check the earnings calendar for the latest scheduling updates across all stocks in our coverage universe.
Should You Buy CC? — Investment Thesis Summary
Chemours Co presents a balanced picture with arguments on both sides. The value score of 74/100 suggests attractive pricing relative to fundamentals. Price momentum is positive at 62/100, suggesting the trend favors buyers. High volatility (stability score 31/100) increases portfolio risk.
In summary, Chemours Co (CC) earns a Hold rating with a composite score of 50.1/100 as of April 2026. The rating is derived from the Blank Capital Research methodology, which combines six factor dimensions into a single quantitative ranking. Investors should consider these quantitative signals alongside their own fundamental research, risk tolerance, and investment time horizon before making buy or sell decisions on CC stock.
We'll email you when stocks you follow change their composite rating.
Institutional Research Dossier
Chemours Co (CC) Deep Dive Analysis
Published on March 24, 2026
Action RatingHold
Sections
Executive Summary
We maintain a Hold rating on Chemours (CC), driven by a mixed outlook. While the company's depressed valuation and potential for cyclical recovery in the Titanium Technologies segment offer upside, significant debt levels, ongoing environmental liabilities, and inconsistent profitability create substantial headwinds. The current composite score of 50.1/100 reflects this balanced risk-reward profile, suggesting limited near-term catalysts for significant outperformance or underperformance.
The primary concern revolves around Chemours' financial leverage and the uncertainty surrounding its environmental liabilities, which overshadow the potential benefits from its market-leading positions in certain chemical segments. A more constructive view would require demonstrable progress in debt reduction, resolution of legal issues, and a sustained improvement in profitability metrics.
Business Strategy & Overview
Chemours operates as a diversified performance chemicals company, organized into four key segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment, responsible for a significant portion of revenue, focuses on TiO2 pigment, a crucial component in coatings, plastics, and paper. This segment's performance is highly correlated with global economic activity and construction markets.
The Thermal & Specialized Solutions segment provides refrigerants and thermal management solutions, benefiting from the increasing demand for energy-efficient cooling systems and the phase-down of older refrigerants under environmental regulations. The Advanced Performance Materials segment offers specialized resins and coatings for various industries, including electronics and transportation, requiring continuous innovation and adaptation to evolving technological demands.
The Chemical Solutions segment provides industrial chemicals used in diverse applications, including gold production and water treatment. Chemours' strategy involves maintaining leading market positions in its core segments through product innovation, operational efficiency, and strategic partnerships. The company sells its products through a mix of direct and indirect channels, leveraging a global network of resellers and distributors to reach a broad customer base.
Chemours' strategic positioning is centered on providing high-performance chemical solutions that address critical industry needs. The company invests in research and development to develop new products and improve existing ones, aiming to stay ahead of the competition and meet evolving customer requirements. A key aspect of their strategy involves navigating increasingly stringent environmental regulations and transitioning to more sustainable chemical solutions.
Execution Benchmarks audit
Revenue Growth
YOY expansion rate
-3.8%
Sector: 1.8%
-317% VS SCTR
Economic Moat Analysis
Chemours' economic moat is best characterized as Narrow. While the company holds leading market positions in certain segments, particularly Titanium Technologies and Thermal & Specialized Solutions, these advantages are not insurmountable. The TiO2 market, while consolidated, is subject to cyclical fluctuations and competition from lower-cost producers, limiting pricing power.
In the Thermal & Specialized Solutions segment, Chemours benefits from intellectual property protection on its newer refrigerants, creating a temporary advantage. However, the long-term sustainability of this moat is uncertain due to the ongoing development of alternative refrigerants and evolving environmental regulations. The Advanced Performance Materials segment relies on specialized resins and coatings, which can provide some differentiation, but these products are often subject to intense competition and technological obsolescence.
The Chemical Solutions segment operates in a more commoditized market, with limited opportunities for differentiation. While Chemours has established relationships with key customers, these relationships are not necessarily exclusive and can be challenged by competitors. The company's intangible assets, such as brand reputation and technical expertise, contribute to its narrow moat, but these assets are not strong enough to create a wide and sustainable competitive advantage.
Switching costs for customers are moderate in some segments, such as Advanced Performance Materials, where specialized formulations are required. However, in other segments, such as Titanium Technologies and Chemical Solutions, switching costs are relatively low, making it easier for customers to switch to alternative suppliers. Overall, Chemours' narrow moat provides some protection against competition, but it is not a dominant or enduring advantage.
Financial Health & Profitability
Chemours' financial health presents a mixed picture. While the company generates substantial revenue, its profitability has been inconsistent, as evidenced by fluctuating net income and operating margins. The TTM revenue of $1.50 billion reflects a decline compared to previous years, indicating challenges in maintaining top-line growth. The net income of $60.00 million is significantly lower than historical levels, highlighting the impact of various factors, including economic headwinds and specific operational issues.
The company's EBITDA of $1.36 billion suggests strong underlying earnings potential, but this is offset by a high debt burden. The total debt of $4.14 billion significantly outweighs the total cash of $613.00 million, resulting in a high debt-to-equity ratio of 2,423.00, far exceeding the sector average of 40.00. This high leverage poses a significant risk, limiting financial flexibility and increasing vulnerability to economic downturns.
The current ratio of 1.71 indicates adequate short-term liquidity, but the long-term financial stability is questionable given the high debt levels. The company's return on equity (ROE) of -117.0% is significantly below the sector average of 2.7%, reflecting poor profitability and inefficient use of equity. The gross margin of 17.3% is also lower than the sector average of 30.2%, indicating challenges in cost management and pricing power.
Analyzing the quarterly financial history reveals volatile performance. While some quarters show strong operating margins, others exhibit significant net losses, indicating inconsistent operational execution and exposure to unforeseen events. The company's free cash flow of $238.20 million provides some cushion, but it may not be sufficient to address the high debt burden and other financial obligations. Overall, Chemours' financial health is concerning, requiring significant improvement in profitability and debt reduction to ensure long-term sustainability.
Valuation Assessment
Chemours' valuation presents a complex picture. The company's P/E ratio of 44.3x is significantly higher than the sector average of 26.1x, suggesting that the stock is relatively expensive compared to its earnings. However, this metric is skewed by the company's recent earnings volatility and may not accurately reflect its underlying value. The EV/EBITDA ratio of 0.5x is substantially lower than the sector average of 5.2x, indicating that the company may be undervalued based on its enterprise value and earnings potential.
The low EV/EBITDA ratio could be attributed to the company's high debt levels and the market's perception of increased risk. Investors may be discounting the stock due to concerns about the company's financial leverage and potential liabilities. The free cash flow yield, while positive, may not be sufficient to justify a higher valuation given the company's other challenges.
Compared to its historical valuation, Chemours' current multiples are depressed, reflecting the recent decline in profitability and increased uncertainty. The stock may be considered a value play, but the potential upside is contingent on the company's ability to improve its financial performance and resolve its outstanding issues. A more conservative valuation approach is warranted given the company's risk profile.
While the low EV/EBITDA might suggest undervaluation, the high debt and inconsistent earnings make it difficult to argue for a strong buy case. The market appears to be pricing in significant risk, and a substantial re-rating would require demonstrable progress in debt reduction, improved profitability, and resolution of legal uncertainties. Therefore, the current valuation appears fair, given the company's challenges and opportunities.
Risk & Uncertainty
Chemours faces several significant risks and uncertainties that could impact its financial performance and stock price. One of the most pressing risks is the ongoing environmental liabilities related to PFAS contamination. The company faces potential legal claims, remediation costs, and regulatory scrutiny, which could result in substantial financial burdens. The uncertainty surrounding these liabilities creates a significant overhang on the stock.
Another key risk is the company's high debt levels. The substantial debt burden limits financial flexibility and increases vulnerability to economic downturns. Rising interest rates could further exacerbate the company's debt servicing costs, putting additional pressure on its profitability. Failure to reduce debt could lead to credit rating downgrades and increased borrowing costs.
The cyclical nature of the Titanium Technologies segment poses another risk. Demand for TiO2 pigment is highly correlated with global economic activity, and a slowdown in economic growth could negatively impact the company's revenue and earnings. Competition from lower-cost producers also poses a threat to the company's market share and pricing power.
Regulatory risks are also significant, particularly in the Thermal & Specialized Solutions segment. The phase-down of older refrigerants and the introduction of new environmental regulations could require the company to invest in new technologies and adapt its product portfolio. Failure to comply with these regulations could result in fines and penalties.
Bulls Say / Bears Say
The Bull Case
BULL VIEWChemours' depressed valuation, particularly its low EV/EBITDA ratio, offers significant upside potential if the company can successfully reduce its debt and resolve its environmental liabilities.
BULL VIEWThe company's leading market positions in key segments, such as Titanium Technologies and Thermal & Specialized Solutions, provide a solid foundation for future growth and profitability as end markets recover.
BULL VIEWSuccessful execution of cost-cutting initiatives and strategic investments in new technologies could drive margin expansion and improve the company's financial performance, leading to a re-rating of the stock.
The Bear Case
BEAR VIEWChemours' high debt levels and ongoing environmental liabilities create significant financial risks that could outweigh any potential benefits from its market-leading positions.
BEAR VIEWThe cyclical nature of the Titanium Technologies segment and increasing competition from lower-cost producers could limit the company's ability to generate sustainable revenue growth and maintain pricing power.
BEAR VIEWThe uncertainty surrounding future environmental regulations and potential legal claims related to PFAS contamination poses a significant threat to the company's long-term financial stability and could lead to further stock price declines.
About the Author
Marques Blank
Founder & Chief Investment Officer, Blank Capital
Marques brings 15 years of institutional finance and investing experience, having overseen financial planning for a $1.6B defense business unit. He developed the proprietary 6-factor quantitative model used to score CC and 4,400+ other equities.
Chemours Co exhibits a 70% valuation premium relative to institutional benchmarks. This represents a potential valuation overextension based on current multiples.
Return on Assets
Efficiency of asset utilization
-4.6%
Sector: 0.6%
Gross Margin
Pricing power and cost efficiency
17.3%
Sector: 29.8%
Operating Margin
Core business profitability
61.4%
Sector: 6.0%
Net Margin
Bottom-line profitability
-5.4%
Sector: 3.0%
Factor Methodology
The Quality factor evaluates the persistence and magnitude of cash flows. Companies with scores >70 exhibit superior competitive moats and financial resilience through economic cycles.
Sector Avg Yield0.49%
Yield Delta+769%
Income Projection audit
A $10,000 investment would generate approximately $426 annually in dividends at the current trailing rate.
